Insulin

PriceWatch: U.S. Cost of Insulin Nearly Triples from 2012 to 2016

Reuters reported that the cost of insulin for treating type 1 diabetes in the U.S. has nearly doubled over a five-period according...

Price Watch: The RESOLVE (PCYC-1137) Phase 3 Updates and IMBRUVICA

AbbVie updated markets via PR NewsWire on its RESOLVE (PCYC-1137) trial which evaluated ibrutinib in combination with chemotherapy agents nab-paclitaxel and gemcitabine...

Price Watch: Novartis’ Canakinumab Reduced by 98% to Reach Accepted Cost Effectiveness

In an interview by MedicalResearch.com, Dr. Thomas S.G. Sehested, MD Department of Cardiology, Copenhagen University Hospital, and Dr. Jenny Bjerre, Department of...

University of Chicago Study Shows Rising Drug Prices Strain Hospitals & Force Budget Cuts

University of Chicago’s NORC  issued a report on the rapidly rising costs of drugs and the devastating impact on hospital budgets, according...
Autism

Phoenix Children’s Receives $1 Mil to Study if Leucovorin Help Autistic Children

AZBig Media reports that the Barrow Neurological Institute (BNI) at Phoenix Children’s Hospital will benefit from two research grants supporting clinical trials...
Pharma Drug Prices

PriceWatch: ODYSSEY Outcomes Trial Reveals Price of Alirocumab Needs to Come Down

As reported in Annals of Internal Medicine, The ODYSSEY Outcomes (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment with Alirocumab) trial...

PriceWatch: GoodRx Lists 20 Most Expensive Drugs for 2018

Tori Marsh writing for GoodRX provides an important list of the 20 top most expensive drugs in 2018. We recommend you select the link...

Diabetes Drug Costs: More Patients and Higher Costs

TrialSite News seeks to bring transparency to clinical trials and the overall drug development industry. With a focus on research sites, we also include...